Previous close | 58.95 |
Open | 59.20 |
Bid | 59.97 x 900 |
Ask | 59.98 x 800 |
Day's range | 59.03 - 60.05 |
52-week range | 57.49 - 89.70 |
Volume | |
Avg. volume | 2,954,191 |
Market cap | 30.171B |
Beta (5Y monthly) | 0.60 |
PE ratio (TTM) | 29.95 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.16 (1.94%) |
Ex-dividend date | 01 Sept 2022 |
1y target est | N/A |
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Shares of Baxter International (NYSE: BAX) were tumbling 8.8% lower as of 11:24 a.m. ET on Thursday after falling as much as 11.8% earlier in the day. The decline came after the healthcare company announced its second-quarter financial results. The company posted Q2 adjusted earnings per share of $0.87, in line with the average estimate of analysts surveyed by Refinitiv.
Baxter's (BAX) second-quarter results reflect the robust performance of the Medication Delivery business unit and Hilrom's businesses.